Background: Depressive disorders, worldwide, may rank second by the year 2020. In India; about 10 million people suffer from depressive disorders, the prevalence rate being recorded as 31.2 for every 1000 individuals. A significant impairment of all personal hygiene may occur due a depressive episode which in turn may result in altered biochemical composition of some important salivary parameters. The present study was conducted in Bhopal, the heart of Madhya Pradesh, India. It was done to assess the relationship and bring about a comparison of certain selective sialochemical alterations between normal and subjects with depressive disorders.

Materials And Methods: The research participants signed a free and informed consent form authorizing their voluntary participation in the research. A total number of 150 subjects were selected and were distributed equally between 3 groups - Group I (normal), Group II (subjects with depressive disorders who were only on psychiatric counseling) and Group III (subjects with depressive disorders who were on medication for at least 1 month). The effect of three antidepressant drugs, which were commonly prescribed by the psychiatrists were considered for the study. Stimulated whole saliva was analyzed biochemically for α-amylase, calcium, sodium, potassium, total proteins, and urea.

Results: Stimulated salivary calcium and total protein levels were found to be statistically significant among all three groups (P < 0.0001). Salivary amylase levels between Groups II and III and between Groups I and III (P < 0.0001) was statistically significant while the salivary urea levels between Groups I and II and between Groups I and III were found to be statistically significant (P < 0.0001). However, there was no statistical difference in their sodium and potassium levels.

Conclusions: It was observed that drugs do affect the salivary composition. It was observed that cyclic antidepressants produced significant alteration in the sialochemical constituents of saliva as compared to tricyclic antidepressants and tetracyclic antidepressants. How to cite the article: Milton BA, Bhambal A, Nair P. Sialochemical analysis: Windfall to the oral physician (A hospital-based clinical cross-sectional study in depressive disorders). J Int Oral Health 2014;6(3):82-9.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107582PMC

Publication Analysis

Top Keywords

depressive disorders
24
subjects depressive
12
groups iii
12
sialochemical analysis
8
analysis windfall
8
windfall oral
8
oral physician
8
physician hospital-based
8
hospital-based clinical
8
clinical cross-sectional
8

Similar Publications

In 2019, intranasal esketamine gained approval as a promising therapy for those individuals grappling with treatment-resistant depression. Both clinical trials and real-world studies have underscored its efficacy in alleviating and remitting depressive symptoms, with sustained benefits observed for nearly 4.5 years.

View Article and Find Full Text PDF

The progress in the field of clinical staging for mental disorders within the last decade: an updated systematic review.

Front Psychiatry

January 2025

Center of Research on Psychological Disorders and Somatic Diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, Netherlands.

Introduction: Clinical staging aims to refine psychiatric diagnosis by describing mental disorders on a continuum of disorder progression, with the pragmatic goal of improved treatment planning and outcome prediction. The first systematic review on this topic, published a decade ago, included 78 papers, and identified separate staging models for schizophrenia, unipolar depression, bipolar disorder, panic disorder, substance use disorder, anorexia, and bulimia nervosa. The current review updates this review by including new proposals for staging models and by systematically reviewing research based upon full or partial staging models since 2012.

View Article and Find Full Text PDF

Objective: This study aimed to summarize and assess the certainty of evidence of non-pharmacological interventions (NPIs) on the depressive outcomes in people with mild cognitive impairment (MCI) based on published systematic reviews (SRs).

Method: Databases including PubMed, EMBASE, PsycINFO, the Cochrane Database of Systematic Reviews, CNKI, CBM, Wanfang and VIP database were searched from their inception to June 6, 2023. The methodological quality of the SRs was evaluated using the AMSTAR2 tool, and the quality of evidence was assessed using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) framework.

View Article and Find Full Text PDF

In the growing field of geriatric psychiatry, the "3 Ds"-depression, dementia, and delirium-are a complex clinical challenge, especially in patients with medical comorbidities. This is a case report of a 96-year-old Saudi woman with chronic kidney disease, heart failure, and recurrent hyponatremia presented with worsening sleep, depression, persecutory delusions, and hallucinations following an intensive care unit (ICU) stay for urinary tract infection. Examination revealed cognitive decline and depressive symptoms, with sodium at 123 mmol/L.

View Article and Find Full Text PDF

Objective: Life interference is a key diagnostic feature for anxiety and depressive disorders. Measures focusing on life interference caused by anxiety and depressive disorders in children and adolescents have received minimal attention. This study evaluated the psychometric properties of the Child Anxiety and Depression Life Interference Scale (CADLIS), a brief child (CADLIS-C) and parent-report (CADLIS-P) measure designed to assess life interference from anxiety and depressive disorders in both the child and parent's life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!